The TenK10K phase‑1 project analyzed over 5 million immune cells from 1,925 donors, revealing common‑variant eQTLs for 83% of genes and rare‑variant signals for nearly half.
The TenK10K phase‑1 project analyzed over 5 million immune cells from 1,925 donors, revealing common‑variant eQTLs for 83% of genes and rare‑variant signals for nearly half.